Ridgecrest Wealth Partners LLC Cuts Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Ridgecrest Wealth Partners LLC reduced its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 5.8% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 10,679 shares of the biopharmaceutical company’s stock after selling 660 shares during the period. Ridgecrest Wealth Partners […]

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Christophers Boerner ,Bristol Myers Squibb ,Pomalyst Imnovid ,Coppell Advisory Solutions Corp ,Capital Management Inc ,Ridgecrest Wealth Partners ,Goldman Sachs Group ,Bristol Myers Squibb Company ,Securities Exchange Commission ,Coppell Advisory Solutions ,True Wealth Design ,Free Report ,Wealth Partners ,Wealth Design ,Advisory Solutions ,Live Oak Investment Partners ,Capital Markets ,Myers Squibb ,Get Free Report ,Myers Squibb Company ,Bristol Myers Squibb Daily ,Nyse Bmy ,Bmy ,Medical ,11012210 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,